Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Heated tension between state and federal AI regulators is coming, predict two attorneys subspecialized in AI startup success, data privacy and cybersecurity.
Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.
Can you guess the (lightly disputed) champion of healthcare AI suppliers? Here’s a hint. This company caters to physicians and just this week reached a valuation of $12B.
Years will pass before the global economy’s healthcare sector sufficiently leverages AI to build major financial muscle off of it. And even then, industry players are likely to see gains well ahead of hospitals and health systems.
The White House held a roundtable discussion on lowering healthcare costs last week. Fortune magazine followed up with one of the panelists, business mogul and Cost Plus Drugs cofounder Mark Cuban.
Have hospitals really taken a step backward along their march toward price transparency? Or is the watchdog outfit making the claim playing fast and loose with the facts?
Given the speed at which generative AI has penetrated every major sector of human endeavor, no expert in any field should pretend to know how to cleanly separate the disruptors from the disrupted.